연구성과로 돌아가기
2020 연구자 정보 (42 / 997)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kim, Y-C. (Kim, YC) |
Chonnam Natl Univ, Sch Med, Hwasun Hosp, Lung Canc Clin,Pulm Med, Jeonnam, South Korea |
|
|
[JCR상위 2.7] South Korean real-world treatment patterns in patients with EGFRm NSCLC | SCIE | 2.7 | ONCOLOGY | |||
|
Klec, Christiane (Klec, C) |
Med Univ Graz, Div Oncol, Graz, Austria |
|
0000-0003-0195-8280 Klec, Christiane |
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | ||
|
Knutsen, Erik (Knutsen, E) |
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway |
ABH-6287-2020 Knutsen, Erik |
0000-0002-4903-0150 Knutsen, Erik |
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | ||
|
Lanza, Giovanni (Lanza, GN) |
Univ Ferrara, Dept Med Sci, Ferrara, Emilia Romagna, Italy |
K-6635-2016 LANZA, GIOVANNI |
0000-0002-5362-1236 LANZA, GIOVANNI |
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | ||
|
Lee, J. C. (Lee, JC) |
제1저자 |
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea Korea Astron & Space Sci Inst, Daejeon, South Korea |
|
|
[JCR상위 2.7] South Korean real-world treatment patterns in patients with EGFRm NSCLC [JCR상위 14.0] Space Telescope and Optical Reverberation Mapping Project. XII. Broad-line Region Modeling of NGC 5548 |
SCIE | 2.7 |
ONCOLOGY ASTRONOMY & ASTROPHYSICS |
pwilliams@astro.ucla.edu; | |
|
Lee, M. A. (Lee, MA) |
Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea |
|
|
[JCR상위 2.7] Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study | SCIE | 2.7 | ONCOLOGY | |||
|
Lee, Sang Kil (Lee, SK) |
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea |
|
0000-0002-0721-0364 Lee, Sang Kil |
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | ||
|
Lim, E. (Lim, E) |
ISU Abxis Co Ltd, Clin Trial Team, Seongnam, South Korea |
|
|
[JCR상위 2.7] Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) | SCIE | 2.7 | ONCOLOGY | |||
|
Lin, J. (Lin, J) |
Mackay Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan |
|
0000-0002-3653-2899 Lin, J |
[JCR상위 2.7] Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study [JCR상위 44.7] Measurement of the integrated luminosity of the Phase 2 data of the Belle II experiment |
SCIE | 2.7 |
ONCOLOGY PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS |
|||
|
Ling, Hui (Ling, H) |
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA |
|
|
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | ||
|
Loncar, Bozo (Loncar, B) |
Dubrava Clin Hosp, Dept Surg, Zagreb, Croatia |
|
|
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | ||
|
Lopez-Berestein, Gabriel (Lopez-Berestein, G) |
교신저자 |
Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA |
|
|
[JCR상위 2.7] Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer | SCIE | 2.7 | GASTROENTEROLOGY & HEPATOLOGY | glopez@mdanderson.org;gcalin@mdanderson.org; | |
|
Nagar, S. P. (Nagar, SP) |
RTI Hlth Solut, Hlth Econ Grp, Durham, NC USA |
|
|
[JCR상위 2.7] South Korean real-world treatment patterns in patients with EGFRm NSCLC | SCIE | 2.7 | ONCOLOGY | |||
|
Park, K. (Park, K) |
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr SMC, Dept Med, Seoul, South Korea Kyungpook Natl Univ, Daegu 41566, South Korea Thomas Jefferson Natl Accelerator Facil, Newport News, VA 23606 USA Thomas Jefferson Natl Accelerator Facil, Newport News, VA USA Kyungpook Natl Univ, Daegu, South Korea |
ABD-5852-2021 Park, Keunchil |
|
[JCR상위 2.7] Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) [JCR상위 23.7] Exclusive π⁰p electroproduction off protons in the resonance region at photon virtualities 0.4 GeV² ≤ Q² ≤ 1 GeV² [JCR상위 7.6] Extraction of Beam-Spin Asymmetries from the Hard Exclusive π⁺ Channel off Protons in a Wide Range of Kinematics [JCR상위 18.4] Beam-target helicity asymmetry E in K⁺Σ⁻ photoproduction on the neutron [JCR상위 0.7] Probing the core of the strong nuclear interaction |
SCIE | 0.7 |
ONCOLOGY PHYSICS, NUCLEAR PHYSICS, MULTIDISCIPLINARY ASTRONOMY & ASTROPHYSICS;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS MULTIDISCIPLINARY SCIENCES |
markov@jlab.org; nicholas@jlab.org; hen@mit.edu; |
||
|
Park, L. C. (Park, LC) |
Kosin Univ Gospel Hosp, Dept Oncol Internal Med, Busan, South Korea |
|
|
[JCR상위 2.7] Phase I dose-expansion (part II) study of ISU104 (a novel anti-ErbB3 monoclonal antibody) alone and combination with cetuximab (CET), in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) | SCIE | 2.7 | ONCOLOGY |
페이지 이동: